FDA Drug Application (022505) for EGRIFTA by THERATECHNOLOGIES

Back to FDA Applications sponsored by THERATECHNOLOGIES

Application Number022505
Product Number001
FormPOWDER;SUBCUTANEOUS
DosageEQ 1MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEGRIFTA
Active IngredientTESAMORELIN ACETATE



Back to FDA Applications sponsored by THERATECHNOLOGIES